Methods of treating skin cancer by administering a PD-1 inhibitor

MYPI2025002758A0Undetermined Publication Date: 2017-11-13REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025002758
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2017-05-12
Filing Date
2017-05-12
Publication Date
2017-11-13
Patent Text Reader

Abstract

The present invention provides methods for treating, reducing the severity, or inhibiting the growth of cancer (e.g., skin cancer). The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a programmed death 1 (PD-1) antagonist (e.g., an anti-PD-1 antibody). In certain embodiments, the skin cancer is cutaneous squamous cell carcinoma or basal cell carcinoma.
Need to check novelty before this filing date? Find Prior Art